The autophagic protein p62 is a target of reactive aldehydes in human and murine cholestatic liver disease.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 05 07 2022
accepted: 17 10 2022
entrez: 15 11 2022
pubmed: 16 11 2022
medline: 19 11 2022
Statut: epublish

Résumé

Inflammatory cholestatic liver diseases, including Primary Sclerosing Cholangitis (PSC), are characterized by periportal inflammation with progression to cirrhosis. The objective of this study was to examine interactions between oxidative stress and autophagy in cholestasis. Using hepatic tissue from male acute cholestatic (bile duct ligated) as well as chronic cholestatic (Mdr2KO) mice, localization of oxidative stress, the antioxidant response and induction of autophagy were analyzed and compared to human PSC liver. Concurrently, the ability of reactive aldehydes to post-translationally modify the autophagosome marker p62 was assessed in PSC liver tissue and in cell culture. Expression of autophagy markers was upregulated in human and mouse cholestatic liver. Whereas mRNA expression of Atg12, Lamp1, Sqstm1 and Map1lc3 was increased in acute cholestasis in mice, it was either suppressed or not significantly changed in chronic cholestasis. In human and murine cholestasis, periportal hepatocytes showed increased IHC staining of ubiquitin, 4-HNE, p62, and selected antioxidant proteins. Increased p62 staining colocalized with accumulation of 4-HNE-modified proteins in periportal parenchymal cells as well as with periportal macrophages in both human and mouse liver. Mechanistically, p62 was identified as a direct target of lipid aldehyde adduction in PSC hepatic tissue and in vitro cell culture. In vitro LS-MS/MS analysis of 4-HNE treated recombinant p62 identified carbonylation of His123, Cys128, His174, His181, Lys238, Cys290, His340, Lys341 and His385. These data indicate that dysregulation of autophagy and oxidative stress/protein damage are present in the same periportal hepatocyte compartment of both human and murine cholestasis. Thus, our results suggest that both increased expression as well as ineffective autophagic degradation of oxidatively-modified proteins contributes to injury in periportal parenchymal cells and that direct modification of p62 by reactive aldehydes may contribute to autophagic dysfunction.

Identifiants

pubmed: 36378690
doi: 10.1371/journal.pone.0276879
pii: PONE-D-22-19030
pmc: PMC9665405
doi:

Substances chimiques

Antioxidants 0
Aldehydes 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0276879

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK048520
Pays : United States
Organisme : NIH HHS
ID : R21 OD026444
Pays : United States
Organisme : NIDDK NIH HHS
ID : R56 DK123738
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG055022
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002535
Pays : United States

Informations de copyright

Copyright: © 2022 Shearn et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Clin Res Hepatol Gastroenterol. 2011 Dec;35(12):792-804
pubmed: 21703962
Biochem Biophys Res Commun. 2009 Nov 20;389(3):431-6
pubmed: 19732748
Toxicol Lett. 2021 Oct 1;349:12-29
pubmed: 34089816
J Hepatol. 2015 Nov;63(5):1220-8
pubmed: 26119688
Br J Pharmacol. 2010 Aug;160(7):1577-9
pubmed: 20649561
Hepatology. 2013 Dec;58(6):2045-55
pubmed: 23775876
J Biol Chem. 2014 May 30;289(22):15449-62
pubmed: 24722988
Mol Aspects Med. 2021 Dec;82:100973
pubmed: 34120768
World J Gastroenterol. 2016 Jul 21;22(27):6192-200
pubmed: 27468209
Gastroenterology. 2013 Sep;145(3):521-36
pubmed: 23827861
Liver Int. 2022 Jul;42(7):1486-1495
pubmed: 35107210
Cell Biosci. 2014 Aug 26;4:47
pubmed: 25922659
Hepatology. 2016 Nov;64(5):1652-1666
pubmed: 27533619
Apoptosis. 2012 Aug;17(8):871-9
pubmed: 22562605
Gut. 2018 Oct;67(10):1864-1869
pubmed: 28739581
Biochemistry. 2011 May 17;50(19):3984-96
pubmed: 21438592
Hepatology. 2019 May;69(5):2196-2213
pubmed: 30520052
Liver Transpl. 2017 Jan;23(1):96-109
pubmed: 27650268
Mol Cell. 2016 Mar 3;61(5):720-733
pubmed: 26942676
Exp Mol Pathol. 2018 Feb;104(1):1-8
pubmed: 29180269
Liver Int. 2017 Oct;37(10):1554-1561
pubmed: 28267887
Mol Pharmacol. 2011 Jun;79(6):941-52
pubmed: 21415306
J Biol Chem. 2021 Jan-Jun;296:100159
pubmed: 33277360
Autophagy. 2017;13(11):1828-1840
pubmed: 28837411
Biochim Biophys Acta Mol Basis Dis. 2021 Feb 1;1867(2):166017
pubmed: 33242590
Mol Cell Oncol. 2021 Mar 9;8(2):1890990
pubmed: 33855170
Cell Stress Chaperones. 2006 Winter;11(4):356-63
pubmed: 17278884
J Biol Chem. 2017 Oct 13;292(41):16817-16824
pubmed: 28842501
J Pediatr Gastroenterol Nutr. 2022 Feb 1;74(2):e21-e26
pubmed: 34789667
Hepatol Commun. 2019 Sep 27;3(12):1674-1686
pubmed: 31832574
Am J Pathol. 1994 Nov;145(5):1237-45
pubmed: 7977654
Hepatology. 2009 Jun;49(6):1982-91
pubmed: 19399914
Scand J Gastroenterol. 2018 Mar;53(3):297-304
pubmed: 29301479
PLoS One. 2018 May 25;13(5):e0198139
pubmed: 29799837
PLoS One. 2021 Jan 7;16(1):e0244743
pubmed: 33411796
JPEN J Parenter Enteral Nutr. 2022 Jul;46(5):1096-1106
pubmed: 34664730
Liver Int. 2012 Mar;32(3):487-99
pubmed: 22098537
Exp Mol Pathol. 2018 Aug;105(1):32-36
pubmed: 29852184
Free Radic Biol Med. 2019 Nov 1;143:101-114
pubmed: 31377417
Hepatology. 2011 May;53(5):1590-9
pubmed: 21351115
Leukemia. 2010 Apr;24(4):679-86
pubmed: 20130602
Autophagy. 2020 Apr;16(4):698-708
pubmed: 31241013
Hepatology. 2012 Feb;55(2):553-62
pubmed: 21953613
Nat Commun. 2021 Jan 4;12(1):16
pubmed: 33397898
Expert Rev Gastroenterol Hepatol. 2017 May;11(5):451-459
pubmed: 28276816
Toxicol Sci. 2014 Feb;137(2):478-90
pubmed: 24189133
Free Radic Biol Med. 1991;11(1):81-128
pubmed: 1937131
Ann Hepatol. 2014 Jul-Aug;13(4):316-26
pubmed: 24927602
Cell Rep. 2017 Jun 27;19(13):2771-2781
pubmed: 28658624
J Hepatol. 2020 Jun;72(6):1122-1131
pubmed: 32001325
Biochem Biophys Res Commun. 2018 Jan 1;495(1):1541-1547
pubmed: 29198703
J Hepatol. 2017 Sep;67(3):549-558
pubmed: 28529147

Auteurs

Colin T Shearn (CT)

Department of Pediatrics, Pediatric Liver Center, Section of Pediatric Gastroenterology, Hepatology and Nutrition, and Children's Hospital Colorado, Aurora, CO, United States of America.

Aimee L Anderson (AL)

Department of Pediatrics, Pediatric Liver Center, Section of Pediatric Gastroenterology, Hepatology and Nutrition, and Children's Hospital Colorado, Aurora, CO, United States of America.

Michael W Devereux (MW)

Department of Pediatrics, Pediatric Liver Center, Section of Pediatric Gastroenterology, Hepatology and Nutrition, and Children's Hospital Colorado, Aurora, CO, United States of America.

David J Orlicky (DJ)

Department of Pathology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.

Cole Michel (C)

Pharmaceutical Sciences, School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.

Dennis R Petersen (DR)

Pharmaceutical Sciences, School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.

Colin G Miller (CG)

Department of Microbiology & Cell Biology, Montana State University, Bozeman, MT, United States of America.

Sanjiv Harpavat (S)

Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States of America.

Edward E Schmidt (EE)

Department of Microbiology & Cell Biology, Montana State University, Bozeman, MT, United States of America.
Laboratory of Redox Biology, Departments of Pharmacology and Physiology, Hungarian Veterinary Medical University, Budapest, Hungary.

Ronald J Sokol (RJ)

Department of Pediatrics, Pediatric Liver Center, Section of Pediatric Gastroenterology, Hepatology and Nutrition, and Children's Hospital Colorado, Aurora, CO, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH